Caricamento...
Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme
We conducted a phase I study to determine (a) the maximum tolerated dose of peri-radiation therapy temozolomide (TMZ) and (b) the safety of a selected hypofractionated intensity modulated radiation therapy (HIMRT) regimen in glioblastoma multiforme (GBM) patients. Patients with histological diagnosi...
Salvato in:
| Pubblicato in: | J Clin Neurosci |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4299456/ https://ncbi.nlm.nih.gov/pubmed/24380758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocn.2013.09.005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|